New Clinical Trial Combines Two Methods to Defeat Ovarian Cancer: UNM Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, January 10, 2017

New Clinical Trial Combines Two Methods to Defeat Ovarian Cancer: UNM



 Blogger's Note: there is no clinical trial reference # in this article

UNM Health Sciences Center
 Media Contacts
  Michele Sequeira
  505-925-0486
  MSequeira@salud.unm.edu

In a new clinical trial Adams is treating women whose ovarian cancer results from mutated BRCA genes with a drug that kills the ovarian cancer cells and another that boosts the immune system in response to the dying cancer cells.
The clinical trial is currently open to women with BRCA1 or BRCA2 mutations who have a higher risk of getting breast and ovarian cancers and may have relatives who had these cancers at young ages.
In pre-clinical studies, this combination therapy eliminated tumors and helped mice to live longer. The clinical trial now makes the therapy available to women with BRCA gene mutations whose ovarian cancer has returned.

0 comments :

Post a Comment

Your comments?